semaglutide diabetes prevention glp-1 prevent glp 1 cardiovascular benefits Beyond the Scale: Surprising of Peptides at Aglow Shows Secondary Cardiovascular – GLP-1-based therapies for diabetes, obesity – A potentially blinding condition Diet Type_Diabetic Friendly Strength:9 mg

semaglutide diabetes prevention glp-1 prevent glp 1 cardiovascular benefits Beyond the Scale: Surprising of Peptides at Aglow Shows Secondary Cardiovascular – GLP-1-based therapies for diabetes, obesity – A potentially blinding condition Diet Type_Diabetic Friendly Strength:9 mg

A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no

A Journal of Functional Foods paper recommended catechin-enriched green tea

Diet Type_Diabetic Friendly

Strength:9 mg

[DOI] [PubMed] [Google Scholar] 58.Bethel M.A., Mentz R.J., Merrill P., Buse J.B., Chan J.C.N., Goodman S.G., Iqbal N., Jakuboniene N., Katona B.G., Lokhnygina Y., et al